{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:14:30Z","timestamp":1776942870540,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Although several histopathological and clinical features of canine mammary gland tumours have been widely studied from a prognostic standpoint, considerable variations in tumour individual biologic behaviour difficult the definition of accurate prognostic factors. It has been suggested that the malignant behaviour of tumours is the end result of several alterations in cellular physiology that culminate in tumour growth and spread. Accordingly, the aim of this study was to determine, using a multivariable model, the independent prognostic value of several immunohistochemically detected tumour-associated molecules, such as MMP-9 and uPA in stromal cells and Ki-67, TIMP-2 and VEGF in cancer cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Eighty-five female dogs affected by spontaneous malignant mammary neoplasias were followed up for a 2-year post-operative period. In univariate analysis, tumour characteristics such as size, mode of growth, regional lymph node metastases, tumour cell MIB-1 LI and MMP-9 and uPA expressions in tumour-adjacent fibroblasts, were associated with both survival and disease-free intervals. Histological type and grade were related with overall survival while VEGF and TIMP-2 were not significantly associated with none of the outcome parameters. In multivariable analysis, only a MIB-1 labelling index higher than 40% and a stromal expression of MMP-9 higher than 50% retained significant relationships with poor overall and disease-free survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The results of this study indicate that MMP-9 and Ki-67 are independent prognostic markers of canine malignant mammary tumours. Furthermore, the high stromal expressions of uPA and MMP-9 in aggressive tumours suggest that these molecules are potential therapeutic targets in the post-operative treatment of canine mammary cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1746-6148-9-1","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T15:14:41Z","timestamp":1357312481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study"],"prefix":"10.1186","volume":"9","author":[{"given":"Andreia A","family":"Santos","sequence":"first","affiliation":[]},{"given":"C\u00e9lia C","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Jorge R","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"Liliana R","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Joana C","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Irina F","family":"Amorim","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"G\u00e4rtner","sequence":"additional","affiliation":[]},{"given":"Augusto J","family":"Matos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,1,4]]},"reference":[{"key":"549_CR1","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/B978-072160558-6.50029-0","volume-title":"Small Animal Clinical Oncology","author":"SE Lana","year":"2007","unstructured":"Lana SE, Rutteman GR, Withrow SJ: Tumors of the mammary gland. Small Animal Clinical Oncology. 4th edition. Edited by: Withrow SJ, MacEwen EG. St. Louis: Saunders Elsevier, 2007, 619-636.","edition":"4th"},{"key":"549_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0195-5616(03)00020-2","volume":"33","author":"K Sorenmo","year":"2003","unstructured":"Sorenmo K: Canine mammary gland tumors. Vet Clin North Am Small Anim Pract. 2003, 33: 573-596. 10.1016\/S0195-5616(03)00020-2.","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"549_CR3","first-page":"16","volume-title":"World Health Organization International Histological Classification of Tumours of Domestic Animals","author":"W Misdorp","year":"1999","unstructured":"Misdorp W, Else RW, Helm\u00e9n E, Lipscomb TP: Histological classification of the mammary tumours of the dog and the cat. World Health Organization International Histological Classification of Tumours of Domestic Animals. 2nd edition. Edited by: Shulman FL. Washington DC: Armed Forces Institute of Pathology, 1999, 16-29.","edition":"2nd"},{"key":"549_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1354\/vp.42-2-200","volume":"42","author":"J De Las Mulas","year":"2005","unstructured":"De Las Mulas J, Mill\u00e1n Y, Dios R: A prospective analysis of immunohistochemically determined estrogen receptor \u03b1 and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the Dog. Vet Pathol. 2005, 42: 200-212. 10.1354\/vp.42-2-200.","journal-title":"Vet Pathol"},{"key":"549_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1476-5829.2009.00193.x","volume":"7","author":"E Ferreira","year":"2009","unstructured":"Ferreira E, Bertagnolli AC, Cavalcanti MF, Schmitt FC, Cassali GD: The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours. Vet Comp Oncol. 2009, 7: 230-235. 10.1111\/j.1476-5829.2009.00193.x.","journal-title":"Vet Comp Oncol"},{"key":"549_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/030098589303000103","volume":"30","author":"E Hellm\u00e9n","year":"1993","unstructured":"Hellm\u00e9n E, Bergstrom R, Holmberg L, Spangberg IB, Hansson K, Lindgren A: Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases. Vet Pathol. 1993, 30: 20-27. 10.1177\/030098589303000103.","journal-title":"Vet Pathol"},{"key":"549_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/104063879801000303","volume":"10","author":"LL Pe\u00f1a","year":"1998","unstructured":"Pe\u00f1a LL, Nieto AI, P\u00e9rez-Alenza D, Cuesta P, Cast\u00e3no M: Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables. J Vet Diagn Invest. 1998, 10: 237-246. 10.1177\/104063879801000303.","journal-title":"J Vet Diagn Invest"},{"key":"549_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcpa.2005.05.003","volume":"133","author":"M Karayannopoulou","year":"2005","unstructured":"Karayannopoulou M, Kaldrymidou E, Constantinidis TC, Dessiris A: Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method. J Comp Pathol. 2005, 133: 1-7. 10.1016\/j.jcpa.2004.11.006.","journal-title":"J Comp Pathol"},{"key":"549_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/104063870201400106","volume":"14","author":"G Sarli","year":"2002","unstructured":"Sarli G, Preziosi R, Benazzi C, Castellani G, Marcato PS: Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumours. J Vet Diagn Invest. 2002, 14: 25-34. 10.1177\/104063870201400106.","journal-title":"J Vet Diagn Invest"},{"key":"549_CR10","first-page":"581","volume":"33","author":"MD P\u00e9rez-Alenza","year":"1997","unstructured":"P\u00e9rez-Alenza MD, Pe\u00f1a L, Nieto I, Casta\u00f1o M: Clinical and pathological prognostic factors in canine mammary tumors. Ann Ist Super Sanita. 1997, 33: 581-585.","journal-title":"Ann Ist Super Sanita"},{"key":"549_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1354\/vp.37-3-239","volume":"37","author":"A Nieto","year":"2000","unstructured":"Nieto A, Pe\u00f1a L, P\u00e9rez-Alenza MD, S\u00e1nchez MA, Flores JM, Cast\u00e3no M: Immunohistologic detection of estrogen receptor alpha in canine mammary tumours: clinical and pathologic associations and prognostic significance. Vet Pathol. 2000, 37: 239-247. 10.1354\/vp.37-3-239.","journal-title":"Vet Pathol"},{"key":"549_CR12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1136\/jcp.2006.041830","volume":"61","author":"RA Walker","year":"2008","unstructured":"Walker RA: Immunohistochemical markers as predictive tools for breast cancer. J Clin Pathol. 2008, 61: 689-696.","journal-title":"J Clin Pathol"},{"key":"549_CR13","first-page":"1821","volume":"26","author":"AJF Matos","year":"2006","unstructured":"Matos AJF, Lopes CCC, Faustino AMR, Carvalheira JGV, Santos MSA, Rutteman GR, G\u00e4rtner MFMR: MIB-1 indices according to clinico-pathological variables in canine mammary tumours: a multivariate study. Anticancer Res. 2006, 26: 1821-1826.","journal-title":"Anticancer Res"},{"key":"549_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00428-008-0644-3","volume":"453","author":"A Gama","year":"2008","unstructured":"Gama A, Alves A, Schmitt F: Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification. Virchows Arch. 2008, 453: 123-132. 10.1007\/s00428-008-0644-3.","journal-title":"Virchows Arch"},{"key":"549_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1746-6148-6-5","volume":"6","author":"F Sassi","year":"2010","unstructured":"Sassi F, Benazzi C, Castellani G, Sarli G: Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry. BMC Vet Res. 2010, 6: 5-10.1186\/1746-6148-6-5.","journal-title":"BMC Vet Res"},{"key":"549_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.tvjl.2007.10.013","volume":"180","author":"W Hsu","year":"2009","unstructured":"Hsu W, Huang H, Liao J, Wong M, Chang S: Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene. The Vet Journal. 2009, 180: 116-123. 10.1016\/j.tvjl.2007.10.013.","journal-title":"The Vet Journal"},{"key":"549_CR17","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.devcel.2010.05.012","volume":"18","author":"M Egeblad","year":"2010","unstructured":"Egeblad M, Nakasone ES, Werb Z: Tumors as organs: complex tissues that interface with the entire organism. Develop Cell. 2010, 18: 884-901. 10.1016\/j.devcel.2010.05.012.","journal-title":"Develop Cell"},{"key":"549_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.acthis.2008.11.022","volume":"112","author":"SA Brooks","year":"2010","unstructured":"Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DMS: Molecular interactions in cancer cell metastasis. Acta Histochem. 2010, 112: 3-25. 10.1016\/j.acthis.2008.11.022.","journal-title":"Acta Histochem"},{"key":"549_CR19","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1136\/vr.142.24.656","volume":"142","author":"JS Morris","year":"1998","unstructured":"Morris JS, Dobson JM, Bostock DE, O\u2019 Farrell E: Effect of ovariohysterectomy in bitches with mammary neoplasms. Vet Record. 1998, 142: 656-658. 10.1136\/vr.142.24.656.","journal-title":"Vet Record"},{"key":"549_CR20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1939-1676.2003.tb01330.x","volume":"17","author":"JC Philibert","year":"2003","unstructured":"Philibert JC, Snyder PW, Glickman N, Knapp DW, Waters DJ: Influence of host factors on survival in dogs with maligant mammary gland tumors. J Vet Intern Med. 2003, 17: 102-106. 10.1111\/j.1939-1676.2003.tb01330.x.","journal-title":"J Vet Intern Med"},{"key":"549_CR21","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1292\/jvms.58.11_1079","volume":"58","author":"T Yamagi","year":"1996","unstructured":"Yamagi T, Kobayashi T, Takahashi K, Sugiyama M: Prognosis for canine malignant mammary tumors based on TNM classification and histologic classification. J Vet Med Sci. 1996, 58: 1079-1083. 10.1292\/jvms.58.11_1079.","journal-title":"J Vet Med Sci"},{"key":"549_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1292\/jvms.66.63","volume":"5","author":"C Lee","year":"2004","unstructured":"Lee C, Kim W, Lim J, Kang M, Kim D, Kweon O: Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors. J Vet Sci. 2004, 5: 63-69.","journal-title":"J Vet Sci"},{"key":"549_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1023\/A:1008329910362","volume":"10","author":"D Rayson","year":"1999","unstructured":"Rayson D, Adjei AA, Suman VJ, Wold LE, Ingle JN: Metaplastic breast cancer: prognosis and response to systemic therapy. Annals of Oncol. 1999, 10: 413-419. 10.1023\/A:1008329910362.","journal-title":"Annals of Oncol"},{"key":"549_CR24","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1136\/jcp.2005.030536","volume":"59","author":"JM Tse","year":"2006","unstructured":"Tse JM, Pan PH, Putti TC, Lui PCW, Chaiwun B, Law BKB: Metaplastic carcinoma of the breast: clinicopathological review. J Clin Pathol. 2006, 59: 1079-1083. 10.1136\/jcp.2005.030536.","journal-title":"J Clin Pathol"},{"key":"549_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1177\/030098589703400306","volume":"34","author":"CV L\u00f6hr","year":"1997","unstructured":"L\u00f6hr CV, Teifke JP, Failing K, Weiss E: Characterization of the proliferation state in canine mammary tumors by the standard AgNOR method with post fixation and immunohistologic detection of Ki-67 and PCNA. Vet Pathol. 1997, 34: 212-221. 10.1177\/030098589703400306.","journal-title":"Vet Pathol"},{"issue":"suppl 1","key":"549_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1634\/theoncologist.5-suppl_1-37","volume":"5","author":"G Gasparini","year":"2000","unstructured":"Gasparini G: Prognostic value of vascular endothelial growth factor in breast cancer. Oncolologist. 2000, 5 (suppl 1): 37-44.","journal-title":"Oncolologist"},{"key":"549_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ygyno.2006.09.031","volume":"104","author":"E Mylona","year":"2007","unstructured":"Mylona E, Alexandrou P, Giannopoulou I, Liapis G, Sofia M, Keramopoulos A, Nakopoulou L: The prognostic value of vascular endothelial growth factors (VEGFs)-A and \u2013B and their receptor, VEGFR-1, in invasive breast carcinoma. Gynecol Oncol. 2007, 104: 557-563. 10.1016\/j.ygyno.2006.09.031.","journal-title":"Gynecol Oncol"},{"key":"549_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/sj.bjc.6603875","volume":"97","author":"Y Nieto","year":"2007","unstructured":"Nieto Y, Woods J, Nawaz F, Baron A, Jones RB, Shpall EJ, Nawaz S: Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy. Br J Cancer. 2007, 97: 391-397. 10.1038\/sj.bjc.6603875.","journal-title":"Br J Cancer"},{"key":"549_CR29","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.rvsc.2006.01.007","volume":"81","author":"F Millanta","year":"2006","unstructured":"Millanta F, Silvestri G, Vaselli C, Citi S, Pisani G, Lorenzi D, Poli A: The role of vascular endothelial growth factor and its receptor Flk-1\/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops. Res Vet Sci. 2006, 81: 350-357. 10.1016\/j.rvsc.2006.01.007.","journal-title":"Res Vet Sci"},{"key":"549_CR30","first-page":"1109","volume":"51","author":"AN Al-Dissi","year":"2010","unstructured":"Al-Dissi AN, Haines DM, Singh B, Kidney BA: Immunohistochemical expression of vascular endothelial growth factor receptor-2 in canine simple mammary gland adenocarcinomas. Can Vet J. 2010, 51: 1109-1111.","journal-title":"Can Vet J"},{"key":"549_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1104819","volume":"307","author":"RK Jain","year":"2005","unstructured":"Jain RK: Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005, 307: 58-62. 10.1126\/science.1104819.","journal-title":"Science"},{"key":"549_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.critrevonc.2003.09.008","volume":"49","author":"E Lambert","year":"2004","unstructured":"Lambert E, Dass\u00e9 E, Haye B, Petitfr\u00e8re E: TIMPs as multifacial proteins. Critical Rev Oncol\/Hematol. 2004, 49: 187-198. 10.1016\/j.critrevonc.2003.09.008.","journal-title":"Critical Rev Oncol\/Hematol"},{"key":"549_CR33","first-page":"1623","volume":"3","author":"AH Ree","year":"1997","unstructured":"Ree AH, Florenes VA, Berg JP, Maelandsmo GM, Nesland JM, Fodstad O: High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) of primary breast carcinomas are associated with development of distant metastases. Clin Cancer Res. 1997, 3: 1623-1628.","journal-title":"Clin Cancer Res"},{"key":"549_CR34","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.humpath.2009.08.027","volume":"41","author":"LO Gonzalez","year":"2010","unstructured":"Gonzalez LO, Junquera S, Del Casar JM, Gonz\u00e1lez L, Mar\u00edn L, Gonz\u00e1lez-Reyes S, Andicoechea A, Gonz\u00e1lez-Fern\u00e1ndez R, Gonz\u00e1lez JM, P\u00e9rez-Fern\u00e1ndez R, Vizoso FJ: Immunohistochemical study of matrix metalloproteinases and their inhibitors in pure and mixed invasive and in situ ductal carcinomas of the breast. Human Pathol. 2010, 41: 980-989. 10.1016\/j.humpath.2009.08.027.","journal-title":"Human Pathol"},{"key":"549_CR35","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.tvjl.2010.12.003","volume":"190","author":"A Santos","year":"2011a","unstructured":"Santos A, Lopes C, Frias C, Amorim I, Vicente C, G\u00e4rtner F, Matos A: Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study. Vet Journal. 2011a, 190: 396-402. 10.1016\/j.tvjl.2010.12.003.","journal-title":"Vet Journal"},{"key":"549_CR36","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/vr.158.18.626","volume":"158","author":"AJF Matos","year":"2006","unstructured":"Matos AJF, Faustino AMR, Lopes C, Rutteman GR, G\u00e4rtner F: Detection of lymph node micrometastases in canine malignant mammary tumours with the use of cytokeratin immunostaining. Vet Record. 2006, 158: 626-629. 10.1136\/vr.158.18.626.","journal-title":"Vet Record"},{"key":"549_CR37","first-page":"365","volume-title":"Rosen\u2019s Breast Pathology","author":"CW Elston","year":"1998","unstructured":"Elston CW, Ellis IO: Assessment of histological grade. Rosen\u2019s Breast Pathology. 1st edition. Edited by: Rosen PP. Philadelphia: Lippincott-Raven Publ, 1998, 365-382.","edition":"1st"},{"key":"549_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jcpa.2010.04.006","volume":"143","author":"AAF Santos","year":"2010","unstructured":"Santos AAF, Oliveira JT, Lopes CCC, Amorim IF, Vicente CMFB, G\u00e4rtner MFMR, Matos AJF: Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours. J Comp Pathol. 2010, 143: 268-275. 10.1016\/j.jcpa.2010.04.006.","journal-title":"J Comp Pathol"},{"key":"549_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tvjl.2010.05.023","volume":"189","author":"A Santos","year":"2011b","unstructured":"Santos A, Lopes C, Marques RM, Amorim I, Ribeiro J, Frias C, Vicente C, G\u00e4rtner F, Matos A: Immunohistochemical analysis of urokinase plasminogen activator and its prognostic value in canine mammary tumours. Vet Journal. 2011b, 189: 43-48. 10.1016\/j.tvjl.2010.05.023.","journal-title":"Vet Journal"},{"key":"549_CR40","first-page":"45","volume-title":"Survival Analysis \u2013 A Self Learning Text","author":"M Klein","year":"2005","unstructured":"Klein M, Kleinbaum DG: Kaplan-Meier survival curves and the Log-rank test. Survival Analysis \u2013 A Self Learning Text. 2nd edition. Edited by: Gail M, Krickeberg K, Samet J, Tsiatis A, Wong W. New York: Springer Science + Business Media LLC, 2005, 45-82.","edition":"2nd"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-6148-9-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:23:46Z","timestamp":1630531426000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/1746-6148-9-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["549"],"URL":"https:\/\/doi.org\/10.1186\/1746-6148-9-1","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,4]]},"assertion":[{"value":"7 October 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"1"}}